Timing of 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients

AIMS: Early studies from the 1990s have shown that statins improve survival and attenuate cardiac allograft vasculopathy (CAV). However, little contemporary data are available on the incremental benefit of statins with the current use of new‐generation immunosuppressive agents and the use of coronar...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ESC Heart Fail
Main Authors: Asleh, Rabea, Briasoulis, Alexandros, Pereira, Naveen L., Boilson, Barry A., Edwards, Brooks S., Adigun, Rosalyn, Maltais, Simon, Daly, Richard C., Lerman, Amir, Kushwaha, Sudhir S.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6300821/
https://ncbi.nlm.nih.gov/pubmed/30019530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12329
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados